$87.77 1.3%
IRTC Stock Price vs. AI Score (Last 150 days)
Data gathered: May 29

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About iRhythm Technologies

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities.


iRhythm Technologies
Price $87.77
Target Price Sign up
Volume 269,200
Market Cap $2.77B
Year Range $72.43 - $123.61
Dividend Yield 0%
Revenue per Employee $286,210
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24132M44M88M-46M-38M0.000
Q4 '23133M45M87M-39M-33M-1.260
Q3 '23125M42M82M-27M-22M-0.890
Q2 '23124M38M86M-18M-14M-0.610
Q1 '23111M36M76M-39M-34M-1.100

Insider Transactions View All

Shrishrimal Sumi filed to sell 24,429 shares at $111.1.
March 5 '24
Turakhia Minang filed to sell 28,659 shares at $111.1.
March 5 '24
Bobzien Brice filed to sell 25,800 shares at $111.1.
March 5 '24
Wilson Daniel G. filed to sell 30,515 shares at $111.1.
March 5 '24
Murphy Patrick Michael filed to sell 47,437 shares at $111.1.
March 5 '24

What is the Market Cap of iRhythm Technologies?

The Market Cap of iRhythm Technologies is $2.77B.

How Many People Work at iRhythm Technologies?

As of our latest update, iRhythm Technologies employed approximately 1,793 people worldwide. However, it's important to note that iRhythm Technologies' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is iRhythm Technologies' revenue per employee?

$286,210. To calculate iRhythm Technologies' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of iRhythm Technologies?

Currently, the price of one share of iRhythm Technologies stock is $87.77.

How can I analyze the IRTC stock price chart for investment decisions?

The IRTC stock price chart above provides a comprehensive visual representation of iRhythm Technologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling iRhythm Technologies shares. Our platform offers an up-to-date IRTC stock price chart, along with technical data analysis and alternative data insights.

Does IRTC offer dividends to its shareholders?

As of our latest update, iRhythm Technologies (IRTC) does not offer dividends to its shareholders. Investors interested in iRhythm Technologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of iRhythm Technologies?

Some of the similar stocks of iRhythm Technologies are Align Technology, Dentsply, LeMaitre Vascular, NovoCure, and Silk Road Medical.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.